Please assess the completion status of the following clinical trial:

Trial Title: Assessment of Myocardial Disease in Man Using Novel Non-invasive Diagnostic Tools

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Over 18 years~* Have provided consent~Risk factor patients also require:~* Hypertension \> 2 years~* Diabetes \> 2 years~* Known ischemia, TIA, or stroke~* Arrhythmia; or reduced renal function (eGFR\<50 ml/min)~Heart Failure patients also require:~* LVEF \<40%~* Receiving standard medication for the treatment of symptomatic systolic heart failure with an NYHA Class of II-IV.~Exclusion Criteria:~Health patients (must not have any of the following):~1. Cardiovascular disease~2. Receiving cardiovascular medication~3. Not in normal sinus rhythm (also required for HF patients)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Healthy subjects (with no evidence of cardiovascular disease).
- 2 (Type: EXPERIMENTAL): Patients with risk factors for heart failure
- 3 (Type: EXPERIMENTAL): Patients with heart failure

Based on this trial design, predict the completion outcome and termination type (if applicable).